Cargando…
Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
The spike protein receptor binding domain (S-RBD) is a necessary corona-viral protein for binding and entry of coronaviruses (COVs) into the host cells. Hence, it has emerged as an attractive antiviral drug target. Therefore, present study was aimed to target severe acute respiratory syndrome corona...
Autores principales: | Muhseen, Ziyad Tariq, Hameed, Alaa R., Al-Hasani, Halah M.H., Tahir ul Qamar, Muhammad, Li, Guanglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538380/ https://www.ncbi.nlm.nih.gov/pubmed/33041407 http://dx.doi.org/10.1016/j.molliq.2020.114493 |
Ejemplares similares
-
Promising Terpenes as Natural Antagonists of Cancer: An In-Silico Approach
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2019) -
Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2021) -
Insights into the Binding of Receptor-Binding Domain (RBD) of SARS-CoV-2 Wild Type and B.1.620 Variant with hACE2 Using Molecular Docking and Simulation Approaches
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2021) -
Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
por: Hoter, Abdullah, et al.
Publicado: (2022) -
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
por: Han, Pengcheng, et al.
Publicado: (2022)